Endoplasmic Reticulum Glycoprotein Quality Control Regulates CD1d Assembly and CD1d-mediated Antigen Presentation

The non-classical major histocompatibility complex (MHC) homologue CD1d presents lipid antigens to innate-like lymphocytes called natural-killer T (NKT) cells. These cells, by virtue of their broad cytokine repertoire, shape innate and adaptive immune responses. Here, we have assessed the role of endoplasmic reticulum glycoprotein quality control in CD1d assembly and function, specifically the role of a key component of the quality control machinery, the enzyme UDP glucose glycoprotein glucosyltransferase (UGT1). We observe that in UGT1-deficient cells, CD1d associates prematurely with β 2 -microglobulin (β 2 m) and is able to rapidly exit the endoplasmic reticulum. At least some of these CD1d-β 2 m heterodimers are shorter-lived and can be rescued by provision of a defined exogenous antigen, α-galactosylceramide. Importantly, we show that in UGT1-deficient cells the CD1d-β 2 m heterodimers have altered antigenicity despite the fact that their cell surface levels are unchanged. We propose that UGT1 serves as a quality control checkpoint during CD1d assembly and further suggest that UGT1-mediated quality control can shape the lipid repertoire of newly synthesized CD1d. The quality control process may play a role in ensuring stability of exported CD1d-β 2 m complexes, in facilitating presentation of low abundance high affinity antigens, or in preventing deleterious responses to self lipids. Background: Various lipid antigens presented by the glycoprotein CD1d strongly influence immune responses. Results: In the absence of endoplasmic reticulum (ER) glycoprotein quality control, CD1d complexes are formed prematurely and have altered antigenicity. Conclusion: ER glycoprotein quality control monitors CD1d assembly and likely influences the loaded lipid repertoire. Significance: Our findings reveal a new mechanism for regulating CD1d-mediated antigen presentation.